8 Results for "

PI4KIIIα

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "PI4KIIIα" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-125118
CAS No.: 1416334-69-4
Purity:  99.04%
Target:  

PI4K HCV

Research Areas:  

Infection

GSK-A1 is a selective type III phosphatidylinositol 4-kinase PI4KA (PI4KIIIα) inhibitor with a pIC50 of 8.5-9.8. GSK-A1 inhibits PtdIns(4,5)P2 resynthesis with an IC50 of about 3 nM. GSK-A1 potently decreases the levels of PtdIns(4)P with a negligible effect on PtdIns(4,5)P2. GSK-A1 has the potential for anti-hepatitis C virus (HCV) research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-106012
CAS No.: 1800017-49-5
Purity:  98.61%
Target:  

PI4K PI3K

Research Areas:  

Cancer

PI4K-IN-1 (compound 44) is a potent PI4KIII inhibitor, with pIC50 values of 9.0 and 6.6 for PI4KIIIα and PI4KIIIβ, respectively. PI4K-IN-1 also inhibits PI3Kα/β/γ/δ, with pIC50 values of 4.0/<3.7/5.0/<4.1, respectively .
loading...
    loading...
Cat. No.: HY-110248
CAS No.: 1715934-43-2
Purity:  99.30%
Target:  

PI4K HCV

Research Areas:  

Infection

MI 14 is a selective PI4KIIIβ inhibitor with IC50s of 54 nM, >100 μM, >100 μM for PI4KIIIβ, PI4KIIIα, PI4KIIα, respectively. MI 14 has antiviral activity against HCV 1b, CVB3, HRVM, HVC 2a .
loading...
    loading...
Cat. No.: HY-100603A
CAS No.: 1384097-27-1
Target:  

PI3K PI4K

Research Areas:  

Infection

(S)-GSK-F1 (Compound 28) is an inhibitor for type III phosphatidylinositol 4-kinase α (PI4KIIIα). (S)-GSK-F1 inhibits PI4Kα, PI4Kβ, PI4Kγ, PI3Kα, PI3Kβ and PI3Kδ with pIC50 of 8.3, 6.0, 5.6, 5.6, 5.1 and 5.6, respectively. (S)-GSK-F1 exhibits anti-hepatitis C virus (HCV) activity through inhibition of HCV replication. (S)-GSK-F1 exhibits moderate pharmacokinetic characters in rat model .
loading...
    loading...
Cat. No.: HY-118525
CAS No.: 869218-90-6
Purity:  99.68%
Target:  

HCV PI4K

Research Areas:  

Infection

AL-9 is a inhibitor of PI4KIIIα, with the IC50 of 0.57 μM, that can inhibit HCV replication .
loading...
    loading...
Cat. No.: HY-161357
CAS No.: 3097359-18-4
Target:  

PI4K

Research Areas:  

Infection

KR-27370 (compound 7f) is an antiviral agent and selective PI4KIIIβ/PI4KIIIα inhibitor (IC50: 3.1 nM/15.8 nM), against hRV, Ke Saatchivirus and other enteroviruses have inhibitory activity .
loading...
    loading...
Cat. No.: HY-123536
CAS No.: 944278-62-0
Synonyms: A-831
Target:  

PI4K HCV

Research Areas:  

Infection

AZD2836 (A-831) is a 4-aminopyrazolone compound with anti-HCV activity. AZD2836 inhibits the activity of the host cell kinase PI4KIIIα, causing metabolic disorder of the cell membrane component PI4P that is necessary for viral replication. In the HCV subgenomic replicon cell model, the EC50 values of AZD2836 for genotype 1b (Con1 strain) and genotype 1a (Lemon strain) are 270 nM and 550 nM, respectively .
loading...
    loading...
Cat. No.: HY-179469
Target:  

PI4K Enterovirus

Research Areas:  

Infection

KR-27452 is a selective and orally active PI4KIIIβ inhibitor with an IC50 of 0.026 μM, while showing no activity against PI4KIIIα (IC50 >10 μM) . KR-27452 specifically binds to and inhibits PI4KIIIβ, leading to reduced viral replication in cells. KR-27452 exhibits strong antiviral activity against human rhinovirus (RVs) and Coxsackievirus (COXs). KR-27452 can be used for the research of infection .
loading...
    loading...